The information in this section about myeloproliferative neoplasms (MPN) can help you talk with members of your healthcare team and take an active role in your treatment. Knowing what to expect and being able to make informed decisions about your cancer treatment are important aspects of coping with your disease. You can skim sections to find what you want to read now - and continue reading whenever you're ready for more information.
What You Should Know
- MPN is a type of blood cancer that includes myelofibrosis, polycythemia vera and essential thrombocythemia.
- Hematologists and oncologists are specialists who treat people who have MPN or other types of blood cancer.
- Researchers are studying new approaches to MPN therapy in clinical trials.
What You Should Do
- Talk with your doctor about all your treatment options and the results you can expect from treatment.
- Talk with your doctor about your diagnostic tests and what the results mean.
What Is MPN?
Myeloproliferative neoplasms (MPN) are types of blood cancer that begin with an abnormal mutation (change) in a stem cell in the bone marrow. The change leads to an overproduction of any combination of white cells, red cells and platelets.
This group of blood disorders includes:
LLS Support Services
The Leukemia & Lymphoma Society (LLS) offers many ways to help you cope, from live telephone support to family support groups to online chats and more. To learn more about our free programs for patients, family members and caregivers, see Get Information and Support.
We also offer free informational publications and education programs, such as:
- fact sheets for MPNs
- the MPN Education Series featuring the latest information about each disease type and treatment options
- eNewsline, a monthly eNewsletter with the latest information about blood cancer research and treatment, LLS events, news and featured LLS programs and comments from individuals coping with blood cancer